Ligand Pharmaceuticals reported $12.8M in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US USD -39945000 3.34M
Amgen AMGN:US USD 3.5B 62M
Arrowhead Research ARWR:US USD -81170000 10.86M
Baxter International BAX:US USD 855M 68M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Clovis Oncology CLVS:US USD -42347000 15.13M
Eli Lilly And LLY:US USD 2.31B 308.9M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
Gilead Sciences GILD:US USD 3.28B 731M
Glaxosmithkline GSK:US GBP 3.36B 916M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Harsco HSC:US USD 71.13M 21.32M
Immunogen IMGN:US USD -77005000 16.41M
Insmed INSM:US USD -119864000 21.78M
Intrexon XON:US USD -5899000 15.79M
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Lannett LCI:US USD -10082000 6.25M
Macrogenics MGNX:US USD -22111000 16.82M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Pfizer PFE:US USD 10.52B 2.78B
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Teva Pharmaceutical Industries TEVA:US USD 1.06B 31M
Veracyte VCYT:US USD -3356000 2.42M